Patent details

91528 Product Name: Etravirine sous toutes formes couvertes par le brevet de base

Basic Information

Publication number:
91528
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP992035907
Legal Status:
Expired
Application number:
91528
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
26/03/2021
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
09/10/2023
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/08/468/001 - INTELENCE - etravirine
Marketing Authorization Type:
Marketing Authorization Date:
01/09/2008
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
18/02/2009
First Marketing Authorization date:
01/09/2008
Grant date:
20/04/2009
Activation date:
01/11/2019
Publication date:
20/04/2009
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
01/09/2023
SPC Extension Expiration:
01/03/2024
Rejection date:
Withdrawal date:

Owner

From:
18/02/2009
 
 

Name:
JANSSEN PHARMACEUTICA N.V.
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/02/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Ludovici Donald William
Address:
United States (US)

2

Name:
Heeres Jan
Address:
Belgium (BE)

3

Name:
Janssen Paul Adriaan Jan
Address:
Belgium (BE)

4

Name:
Van Aken Koen Jeanne Alfons
Address:
Belgium (BE)

5

Name:
Ho Chih Yung
Address:
United States (US)

6

Name:
Kavash Robert W.
Address:
United States (US)

7

Name:
De Corte Bart
Address:
United States (US)

8

Name:
Kukla Michael Joseph
Address:
United States (US)

9

Name:
Koymans Lucien Maria Henricus
Address:
Belgium (BE)

10

Name:
De Jonge Marc René
Address:
Netherlands (NL)

Publication

Bulletin

1

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:
SPC3
Bulletin edition number:
2019/13
Publication date:
20/12/2019
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

3

Bulletin Heading:
SPCX1
Bulletin edition number:
2021/05
Publication date:
13/04/2021
Description:
Section G : Applications for extensions for pediatric use – I1E publication

4

Bulletin Heading:
SPCX2
Bulletin edition number:
2023/12
Publication date:
06/11/2023
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/10/2022
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
09/10/2023 Publication 1
09/10/2023 Certificate 1
26/03/2021 FNET_DC_FRONTPAGE 1
09/10/2023 Outgoing Correspondence 1
26/03/2021 Publication 1
02/01/2019 Publication 1
26/03/2021 Summary of the product caracteristics 71
26/03/2021 Application Form 3
26/03/2021 Marketing authorization 5
25/07/2018 Incoming Correspondence (Post) 2
26/03/2021 Outgoing Correspondence 1
26/03/2021 Paediatric investigation plan 1
02/01/2019 Outgoing Correspondence 1
26/03/2021 General Document 1